Related Experiment Video
Updated: Jul 19, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
New antimicrobial agents for Gram-positive infections
1Departments of Medicine, Division of Infectious Diseases and Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.
Antimicrobial resistance in Gram-positive bacteria is a growing concern. New drug classes are in development to combat resistant infections like vancomycin-resistant enterococci and Staphylococcus aureus.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Rising antimicrobial resistance in Gram-positive bacteria poses significant treatment challenges.
- Vancomycin resistance in enterococci is associated with high mortality rates (approx. 40%).
- Widespread vancomycin resistance in Staphylococcus aureus would have a more severe impact due to its virulence.
Purpose of the Study:
- To review advances in developing new antimicrobial agents against multiply resistant Gram-positive bacteria.
- To highlight the emergence of novel antimicrobial classes.
Main Methods:
- Review of pharmacological developments since the late 1980s.
- Analysis of antimicrobial classes targeting resistant Gram-positive organisms.
Main Results:
- Several new antimicrobial classes with activity against resistant Gram-positive bacteria are under development.
- At least seven new classes are in various stages of development.
- A unique class of antimicrobial agent has emerged alongside semisynthetic derivatives.
Conclusions:
- Ongoing research is yielding new therapeutic options for multidrug-resistant Gram-positive infections.
- The development pipeline includes both modifications of existing antibiotics and novel agents.
Related Concept Videos
Antimicrobial Effectiveness
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Chemical Agents for Microbial Control
Clinical Significance of Antibiotic Resistance

